XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 1,333,000,000 $ 1,053,400,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 441,900,000 511,200,000
Deferred income taxes 27,000,000.0 131,300,000
Share-based compensation expense related to equity incentive plans 89,900,000 82,500,000
Loss on settlement of debt 12,200,000 8,300,000
Amortization of debt discount 4,800,000 3,600,000
Amortization of debt issuance costs 4,000,000.0 4,700,000
Impairment of intangible assets 1,100,000 0
Other non-cash adjustment (100,000) (2,300,000)
Changes in operating assets and liabilities, excluding impact of acquisitions:    
Increase in accounts receivable (400,900,000) (60,600,000)
Increase in inventories (5,100,000) (190,200,000)
Increase in accounts payable and accrued liabilities 64,000,000.0 144,300,000
Change in other assets and liabilities 63,900,000 (10,600,000)
Change in income tax payable (26,300,000) (42,000,000.0)
Net cash provided by operating activities 1,609,400,000 1,633,600,000
Cash flows from investing activities:    
Proceeds from sales of assets 400,000 400,000
Investments in other assets (49,600,000) (52,800,000)
Capital expenditures (185,500,000) (232,200,000)
Net cash used in investing activities (234,700,000) (284,600,000)
Cash flows from financing activities:    
Proceeds from Issuance of Commercial Paper 995,000,000.0 0
Repayment of senior notes (2,000,000,000) 0
Payments on settlement of convertible debt (132,800,000) (170,400,000)
Deferred financing costs (1,000,000.0) 0
Proceeds from sale of common stock 40,600,000 37,800,000
Tax payments related to shares withheld for vested RSUs (30,400,000) (40,100,000)
Repurchase of common stock (480,100,000) (442,400,000)
Payment of cash dividends (431,600,000) (319,100,000)
Capital lease payments (800,000) (400,000)
Net cash used in financing activities (1,352,100,000) (1,361,600,000)
Net increase (decrease) in cash and cash equivalents 22,600,000 (12,600,000)
Cash and cash equivalents, and restricted cash at beginning of period 234,000,000.0 317,400,000
Cash and cash equivalents, and restricted cash at end of period 256,600,000 304,800,000
Revolving Credit Facility    
Cash flows from financing activities:    
Proceeds from lines of credit 5,551,000,000 2,765,000,000
Repayments of line of credit (5,612,000,000) (3,192,000,000)
Term Loan Facility    
Cash flows from financing activities:    
Proceeds from lines of credit $ 750,000,000.0 $ 0